Association of CD34/CD133/VEGFR2-Positive Cell Numbers with Eicosapentaenoic Acid and Postprandial Hyperglycemia in Patients with Coronary Artery Disease

International Journal of Cardiology

Volumn 221, Issue , 2016, Pages 1039-1042

  Morishita, Tetsuji ^a   Uzui, Hiroyasu ^a   Ikeda, Hiroyuki ^a   Amaya, Naoki ^a   Kaseno, Kenichi ^a   Ishida, Kentaro ^a   Fukuoka, Yoshitomo ^a   Lee, Jong Dae ^a   Tada, Hiroshi ^a  

^a UNIVERSITY OF FUKUI   (Japan)

Author keywords

1,5 anhydro D glucitol; body mass index; eicosapentaenoic acid; endothelial progenitor cell

Indexed keywords

1,5 ANHYDROSORBITOL; ARACHIDONIC ACID; CD133 ANTIGEN; CD34 ANTIGEN; HEMOGLOBIN A1C; ICOSAPENTAENOIC ACID; VASCULOTROPIN RECEPTOR 2; 1,5-ANHYDROGLUCITOL; DEOXYGLUCOSE;

AGED; ARTICLE; BODY MASS; CORONARY ARTERY DISEASE; CROSS-SECTIONAL STUDY; ENDOTHELIAL PROGENITOR CELL; FEMALE; HUMAN; HUMAN CELL; HYPERGLYCEMIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POSTPRANDIAL STATE; PRIORITY JOURNAL; CELL COUNT; COMPLICATION; DIABETES MELLITUS, TYPE 2; METABOLISM; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROCEDURES; RISK FACTOR; STEM CELL; VASCULAR ENDOTHELIUM;

AC133 ANTIGEN; AGED; ANTIGENS, CD34; CELL COUNT; CORONARY ARTERY DISEASE; DEOXYGLUCOSE; DIABETES MELLITUS, TYPE 2; EICOSAPENTAENOIC ACID; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; RISK FACTORS; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84978532194     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.07.079     Document Type: Article

References (36)

1. [1] Werner, N., Kosiol, S., Schiegl, T., Ahlers, P., Walenta, K., Link, A., et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N. Engl. J. Med. 353 (2005), 999–1007.
2. [2] Schmidt-Lucke, C., Rössig, L., Fichtlscherer, S., Vasa, M., Britten, M., Kämper, U., et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 111 (2005), 2981–2987.
3. [3] Fadini, G.P., Sartore, S., Albiero, M., Baesso, I., Murphy, E., Menegolo, M., et al. Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler. Thromb. Vasc. Biol. 26 (2006), 2140–2146.
4. [4] Vasa, M., Fichtlscherer, S., Aicher, A., Adler, K., Urbich, C., Martin, H., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ. Res. 89 (2001), E1–E7.
5. [5] Hill, J.M., Zalos, G., Halcox, J.P., Schenke, W.H., Waclawiw, M.A., Quyyumi, A.A., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 348 (2003), 593–600.
6. [6] António, N., Fernandes, R., Soares, A., Soares, F., Lopes, A., Carvalheiro, T., et al. Reduced levels of circulating endothelial progenitor cells in acute myocardial infarction patients with diabetes or pre-diabetes: accompanying the glycemic continuum. Cardiovasc. Diabetol., 13, 2014, 101.
7. [7] Hörtenhuber, T., Rami-Mehar, B., Satler, M., Nagl, K., Höbaus, C., Höllerl, F., et al. Endothelial progenitor cells are related to glycemic control in children with type 1 diabetes over time. Diabetes Care 36 (2013), 1647–1653.
8. [8] Yamanouchi, T., Akanuma, Y., Serum 1,5-anhydroglucitol (1,5 AG): new clinical marker for glycemic control. Diabetes Res. Clin. Pract. 24:Suppl. (1994), S261–S268.
9. [9] Stettler, C., Stahl, M., Allemann, S., Diem, P., Schmidlin, K., Zwahlen, M., et al. Association of 1,5-anhydroglucitol and 2-h postprandial blood glucose in type 2 diabetic patients. Diabetes Care 31 (2008), 1534–1535.
10. [10] Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Saito, Y., Ishikawa, Y., et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet 369 (2007), 1090–1098.
11. [11] Marchioli, R., Barzi, F., Bomba, E., Chieffo, C., Di Gregorio, D., Di Mascio, R., et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 105 (2002), 1897–1903.
12. [12] Tavazzi, L., Maggioni, A.P., Marchioli, R., Barlera, S., Franzosi, M.G., Latini, R., et al. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 372 (2008), 1223–1230.
13. [13] Burr, M.L., Fehily, A.M., Gilbert, J.F., Rogers, S., Holliday, R.M., Sweetnam, P.M., et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet 2 (1989), 757–761.
14. [14] Dolecek, T.A., Granditis, G., Dietary polyunsaturated fatty acids and mortality in the Multiple Risk Factor Intervention Trial (MRFIT). World Rev. Nutr. Diet. 66 (1991), 205–216.
15. [15] Chowdhury, R., Warnakula, S., Kunutsor, S., Crowe, F., Ward, H.A., Johnson, L., et al. Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann. Intern. Med. 160 (2014), 398–406.
16. [16] Ramsden, C.E., Zamora, D., Majchrzak-Hong, S., Faurot, K.R., Broste, S.K., Frantz, R.P., et al. Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968-73). BMJ, 353, 2016, i1246.
17. [17] Ramsden, C.E., Zamora, D., Leelarthaepin, B., Majchrzak-Hong, S.F., Faurot, K.R., Suchindran, C.M., et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ, 346, 2013, e8707.
18. [18] Devaraj, S., Chien, A., Rao, B., Chen, X., Jialal, I., Modulation of endothelial progenitor cell number and function with n-3 polyunsaturated fatty acids. Atherosclerosis 228 (2013), 94–97.
19. [19] Turgeon, J., Dussault, S., Maingrette, F., Groleau, J., Haddad, P., Perez, G., et al. Fish oil-enriched diet protects against ischemia by improving angiogenesis, endothelial progenitor cell function and postnatal neovascularization. Atherosclerosis 229 (2013), 295–303.
20. [20] Chiu, S.C., Chiang, E.P., Tsai, S.Y., Wang, F.Y., Pai, M.H., Syu, J.N., et al. Eicosapentaenoic acid induces neovasculogenesis in human endothelial progenitor cells by modulating c-kit protein and PI3-K/Akt/eNOS signaling pathways. J. Nutr. Biochem. 25 (2014), 934–945.
21. [21] Watanabe, K., Uchino, H., Ohmura, C., Tanaka, Y., Onuma, T., Kawamori, R., Different effects of two alpha-glucosidase inhibitors, acarbose and voglibose, on serum 1,5-anhydroglucitol (1,5AG) level. J. Diabetes Complicat. 18 (2004), 183–186.
22. [22] Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 20, 1997, 1183–1197.
23. [23] Morishita, T., Uzui, H., Nakano, A., Mitsuke, Y., Geshi, T., Ueda, T., et al. Number of endothelial progenitor cells in peripheral artery disease as a marker of severity and association with pentraxin-3, malondialdehyde-modified low-density lipoprotein and membrane type-1 matrix metalloproteinase. J. Atheroscler. Thromb. 19 (2012), 149–158.
24. [24] Ouchi, M., Oba, K., Motoyama, M., Tsunoda, M., Yamashita, H., Aoyama, J., et al. Postprandial glycemic control conditions in relation to urinary N-acetyl-β-D-glucosaminidase in patients with type 2 diabetes mellitus without low glomerular filtration rate. Diabetes Technol. Ther. 16 (2014), 41–47.
25. [25] Watanabe, M., Kokubo, Y., Higashiyama, A., Ono, Y., Miyamoto, Y., Okamura, T., Serum 1,5-anhydro-D-glucitol levels predict first-ever cardiovascular disease: an 11-year population-based cohort study in Japan, the Suita study. Atherosclerosis 216 (2011), 477–483.
26. [26] Morishita, T., Uzui, H., Mitsuke, Y., Arakawa, K., Amaya, N., Kaseno, K., et al. Predictive utility of the changes in matrix metalloproteinase-2 in the early phase for left ventricular reverse remodeling after an acute myocardial infarction. J. Am. Heart Assoc., 4, 2015, e001359.
27. [27] Lang, R.M., Bierig, M., Devereux, R.B., Flachskampf, F.A., Foster, E., Pellikka, P.A., et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J. Am. Soc. Echocardiogr. 18 (2005), 1440–1463.
28. [28] Sohn, D.W., Chai, I.H., Lee, D.J., Kim, H.C., Kim, H.S., Oh, B.H., et al. Assessment of mitral annulus velocity by Doppler tissue imaging in the evaluation of left ventricular diastolic function. J. Am. Coll. Cardiol. 30 (1997), 474–480.
29. [29] Valgimigli, M., Rigolin, G.M., Fucili, A., Porta, M.D., Soukhomovskaia, O., Malagutti, P., et al. CD34 + and endothelial progenitor cells in patients with various degrees of congestive heart failure. Circulation 110 (2004), 1209–1212.
30. [30] Kissel, C.K., Lehmann, R., Assmus, B., Aicher, A., Honold, J., Fischer-Rasokat, U., et al. Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure. J. Am. Coll. Cardiol. 49 (2007), 2341–2349.
31. [31] Michowitz, Y., Goldstein, E., Wexler, D., Sheps, D., Keren, G., George, J., Circulating endothelial progenitor cells and clinical outcome in patients with congestive heart failure. Heart 93 (2007), 1046–1050.
32. [32] Nonaka-Sarukawa, M., Yamamoto, K., Aoki, H., Nishimura, Y., Tomizawa, H., Ichida, M., et al. Circulating endothelial progenitor cells in congestive heart failure. Int. J. Cardiol. 119 (2007), 344–348.
33. [33] Bonetti, P.O., Lerman, L.O., Lerman, A., Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler. Thromb. Vasc. Biol. 23 (2003), 168–175.
34. [34] Graziani, F., Leone, A.M., Basile, E., Cialdella, P., Tritarelli, A., Bona, R.D., et al. Endothelial progenitor cells in morbid obesity. Circ. J. 78 (2014), 977–985.
35. [35] Steiner, S., Niessner, A., Ziegler, S., Richter, B., Seidinger, D., Pleiner, J., et al. Endurance training increases the number of endothelial progenitor cells in patients with cardiovascular risk and coronary artery disease. Atherosclerosis 181 (2005), 305–310.
36. [36] Bruyndonckx, L., Hoymans, V.Y., Frederix, G., De Guchtenaere, A., Franckx, H., Vissers, D.K., et al. Endothelial progenitor cells and endothelial microparticles are independent predictors of endothelial function. J. Pediatr. 165 (2014), 300–305.